KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) EPS (Weighted Average and Diluted) (2016 - 2025)

Bausch Health Companies' EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at -$0.3 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 220.0% year-over-year to -$0.3; the TTM value through Dec 2025 reached $0.42, up 423.08%, while the annual FY2025 figure was $0.42, 423.08% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.3 at Bausch Health Companies, down from $0.48 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.1 in Q3 2022 and bottomed at -$1.71 in Q1 2021.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.16 (2024), against an average of -$0.23.
  • The largest annual shift saw EPS (Weighted Average and Diluted) tumbled 638.1% in 2022 before it skyrocketed 1233.33% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.21 in 2021, then crashed by 638.1% to -$1.13 in 2022, then soared by 91.15% to -$0.1 in 2023, then skyrocketed by 350.0% to $0.25 in 2024, then crashed by 220.0% to -$0.3 in 2025.
  • Per Business Quant, the three most recent readings for BHC's EPS (Weighted Average and Diluted) are -$0.3 (Q4 2025), $0.48 (Q3 2025), and $0.4 (Q2 2025).